FIT-(BCMA+CD19)-CAR-T cell therapy
/ Beijing Boren Hospital
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 07, 2026
FIT-(BCMA+CD19)-CAR-T Cells in Recurrent/Refractory Autoimmune Diseases Patients.
(clinicaltrials.gov)
- P1 | N=9 | Suspended | Sponsor: Beijing Boren Hospital | Enrolling by invitation ➔ Suspended
Trial suspension • Immunology
1 to 1
Of
1
Go to page
1